abstract |
The present invention relates to a compound used as NTRK kinase inhibitor and its application. In particular, the present invention relates to a compound represented by formula I or a stereoisomer or optical isomer, pharmaceutically acceptable salt, prodrug or solvate thereof, and also relates to a pharmaceutical composition of the compound and its use as a NTRK kinase inhibitor, and use in the preparation of a medicament for preventing and/or treating NTRK-related diseases. |